Top Markets
Coin of the day
Fennec Pharmaceuticals Inc. Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc.

FENC
Rank in Stocks #14205
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading... Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading investigational drug in clinical development is PEDMARK, a specialized formulation of sodium thiosulfate. This treatment is designed to shield young cancer patients from hearing damage (ototoxicity) that can be induced by platinum-based chemotherapy. The company, which was founded in 1996, previously operated under the name Adherex Technologies Inc. before officially rebranding as Fennec Pharmaceuticals Inc. in September 2014. Its corporate headquarters are situated in Research Triangle Park, North Carolina.
Share Price
$12.33
Last synced: 2026-08-31
Market Cap
$428.31M
Change (1 day)
0.49%
Change (1 year)
39.01%
Country
US
Trade Fennec Pharmaceuticals Inc. (FENC)

Category

Stock split history for Fennec Pharmaceuticals Inc. (FENC)
Fennec Pharmaceuticals Inc. stock (symbol: FENC) underwent a total of 0 stock splits.
The most recent stock split occurred on Sep 01, 2026.
One FENC share bought prior to Sep 01, 2026 would equal to 0 FENC shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH